Hutchison China MediTech Ltd ADR Stock
Currently there is a rather positive sentiment for Hutchison China MediTech Ltd ADR with 3 Buy predictions and 1 Sell predictions.
As a result the target price of 17 € shows a positive potential of 42.86% compared to the current price of 11.9 € for Hutchison China MediTech Ltd ADR.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | - | -4.032% | -10.526% | -24.684% | -11.194% | -8.462% | -50.000% |
| China Resources Pharmaceutical Group Ltd | -0.950% | -0.952% | -3.704% | -17.460% | -22.963% | -32.903% | 22.642% |
| China Traditional Chinese Medicine Co Ltd | -0.820% | -2.419% | -0.820% | -9.701% | -11.029% | -48.729% | -38.579% |
| Repligen Corp. | -0.880% | -4.547% | 11.619% | 0.248% | 1.250% | -16.852% | -8.698% |
Comments
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $13.75 price target on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat